Edition:
United Kingdom

Zafgen Inc (ZFGN.OQ)

ZFGN.OQ on NASDAQ Stock Exchange Global Select Market

3.79USD
15 Dec 2017
Change (% chg)

$0.09 (+2.43%)
Prev Close
$3.70
Open
$3.70
Day's High
$3.88
Day's Low
$3.70
Volume
17,806
Avg. Vol
20,265
52-wk High
$5.43
52-wk Low
$3.16

Latest Key Developments (Source: Significant Developments)

Zafgen reports Q3 loss per share $0.46
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Zafgen Inc :Zafgen reports third quarter 2017 financial results.Q3 loss per share $0.46.Q3 earnings per share view $-0.58 -- Thomson Reuters I/B/E/S.Zafgen- continues to expect its cash, cash equivalents and marketable securities balance to be greater than $70 million as of december 31, 2017​.Zafgen Inc - ‍initiated phase 2 clinical trial for second generation metap2 inhibitor ZGN-1061​.  Full Article

Zafgen appoints Jeffrey Hatfield as CEO
Tuesday, 10 Oct 2017 

Oct 10 (Reuters) - Zafgen Inc ::Zafgen appoints Jeffrey Hatfield as Chief Executive Officer; Thomas Hughes, Ph.D. to continue as president, appointed chief scientific officer.Zafgen Inc - Hatfield and Hughes will serve on Zafgen's board of directors​.  Full Article

Zafgen posts Q2 shr loss $0.55
Thursday, 4 Aug 2016 

Zafgen Inc : Q2 loss per share $0.55 . Zafgen reports second quarter 2016 financial results . Q2 earnings per share view $-0.66 -- Thomson Reuters I/B/E/S .Says expects that its cash, cash equivalents and marketable securities balance will be greater than $125 million at december 31, 2016.  Full Article

Zafgen Q1 loss per share $0.65
Tuesday, 10 May 2016 

Zafgen Inc : Reported a net loss for q1 of $0.65 per share . Expects that its cash, cash equivalents and marketable securities balance will be greater than $100 million at December 31, 2016 . Zafgen inc says expect to have more clarity on potential path forward for beloranib in PWS over next few months . Zafgen reports first quarter 2016 financial results . Q1 loss per share $0.65 .Q1 earnings per share view $-0.74 -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-Zafgen reports Q3 loss per share $0.46

* Q3 earnings per share view $-0.58 -- Thomson Reuters I/B/E/S